Vaccine protects mice from 1918 flu virus

Oct 17, 2006

U.S. medical researchers say they've developed a vaccine that protects mice against the killer 1918 influenza virus.

The National Institutes of Health scientists say they also have created a technique for identifying antibodies that neutralize that deadly virus, a tool that could help contain future pandemic flu strains.

The findings are important to understanding and preventing the recurrence of the H1N1 influenza virus that caused the 1918 pandemic, and for protecting against virulent flu strains in the future, including the H5N1 avian flu virus.

"Understanding why this influenza virus was so deadly is an extremely important question," said NIAID Director Dr. Anthony Fauci "By building upon earlier research where scientists successfully reconstructed the 1918 pandemic flu strain, Dr. Nabel and his colleagues have demonstrated that this virus is vulnerable to intervention.

The 1918-1919 influenza pandemic was the most deadly flu outbreak in modern history, killing 50 million or more people worldwide.

The study -- led by Dr. Gary Nabel, director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases -- appears online in the Proceedings of the National Academy of Sciences.

Copyright 2006 by United Press International

Explore further: Express Scripts turns to AbbVie in huge hepatitis C deal (Update)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.